CVS Health earnings top estimates as Covid vaccinations, testing boost drugstore sales


People walk by a CVS Pharmacy store in the Manhattan borough of New York City.
Shannon Stapleton | Reuters

CVS Health reported a strong first quarter and raised its full-year forecast, as customers came to its stores for Covid-19 vaccinations, tests and prescriptions.

Shares of the company were up 3% early Tuesday in premarket trading.

Here’s what the company reported for the fiscal first quarter ended March 31, compared with what analysts were expecting, based on a survey of analysts by Refinitiv:

  • Earnings per share: $2.04, adjusted vs. $1.72 expected
  • Revenue: $69.1 billion vs. $68.39 billion expected

The health-care company and drugstore chain reported net income of $2.22 billion, or $1.68 per share, up from $2.01 billion, or $1.53 per share, a year earlier.

Excluding items, it earned $2.04 per share, more than the $1.72 per share expected by analysts surveyed by Refinitiv.

Revenue rose to $69.1 billion from $66.8 billion a year earlier. That outpaced analysts’ expectations of $68.39 billion.

CVS is a major provider of Covid-19 vaccines and recently began offering same-day appointments for the shots.

As of Monday’s close, shares of CVS were up nearly 14% this year. They closed at $77.69 on Monday, bringing the company’s market value to $101.97 billion.

Read full release here.

This story is developing. Please check back for updates.

Products You May Like

Articles You May Like

5 Reliable Retirement Investments For A Low-Interest Rate Environment
Social Security beneficiaries urged to file tax returns to get missing stimulus checks
Mark Cuban: The 3 ways Ethereum ‘dwarfs’ bitcoin
What you need to know about Greg Abel — Warren Buffett’s successor at Berkshire Hathaway
Treasury Secretary’s IRS Praise Sparks Backlash From Those Who Must Deal With The Tax Agency

Leave a Reply

Your email address will not be published. Required fields are marked *